Interim results from a phase I/II study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T cell engager in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine neoplasms (NEN) Meeting Abstract
| Authors: | Choudhury, N.; Jain, P.; Dowlati, A.; Thompson, J.; Johnson, M. L.; Mamdani, H.; Sanborn, R. E.; Schenk, E. L.; Aggarwal, R.; Sankar, K.; Walker, L. N.; Anand, B.; Beltran, H. |
| Abstract Title: | Interim results from a phase I/II study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T cell engager in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine neoplasms (NEN) |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S486 |
| Language: | English |
| ACCESSION: | WOS:001087480201040 |
| DOI: | 10.1016/j.annonc.2023.09.1884 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 698P -- Source: Wos |
